Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Lifestyle Modification and Incretin Therapy for Individuals With Obesity

To the Editor A recent JAMA Insights article proposed that lifestyle modification be reconceived as an adjunct to incretin-based therapy rather than its foundation, noting that even low-intensity counseling preserves most of the weight loss achieved with semaglutide and tirzepatide. Although this reframing is reasonable for weight reduction, it risks understating when nutritional guidance should…

We haven't written up this one. JAMA has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at jamanetwork.com →

More in Health & Medicine

BDMS invests in gene therapy

Bangkok Dusit Medical Services Plc (BDMS) has invested 170 million baht in General Network Photonics Thailand, a developer of gene therapy for leukaemia treatment, as the hospital group seeks to…

More from Tuesday 20 October →